Results 331 to 340 of about 218,068 (352)

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

Nature Medicine, 2021
Sara Ghorashian, Ajay Vora, Giovanna Lucchini   +2 more
exaly  

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine, 2023
Timothy A Yap, Naval G Daver, Jixiang Zhang   +2 more
exaly  

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Increased cancer burden among pesticide applicators and others due to pesticide exposure

Ca-A Cancer Journal for Clinicians, 2013
Matthew R Bonner
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Acute Lymphoblastic Leukemia

2005
openaire   +1 more source

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Nature Medicine, 2018
Joseph A Fraietta, Simon F Lacey, Yan Wang   +2 more
exaly  

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Nature Medicine, 2018
Daniel A Pollyea, Shanshan Pei, Angelo D'Alessandro   +2 more
exaly  

Somatic mutations precede acute myeloid leukemia years before diagnosis

Nature Medicine, 2018
Pinkal Desai, Nuria Mencia-Trinchant, Oleksander Savenkov   +2 more
exaly